CHAPEL HILL, N.C., Oct. 17, 2018 /PRNewswire/ -- An effective field-based medical team is especially crucial for rare diseaseproducts.
MSLs and other field specialists are expected to develop and maintain the relationship with key rare disease experts as well as build well-informed advocacy base for a company's rare disease franchise. Best Practices, LLC recently conducted
"Rare Diseases: What it Takes to Build Strong Field-based Medical Teams" provides operational guideposts and specific answers to questions such as:
The study found that MSLs are typically the primary contacts who engage with HCPs and KOLs; about 50 and 40 HCP and KOL interactions a year, respectively, are made by field teams.
For this research, Best Practices, LLC engaged 15 leaders from 12 companies through a benchmarking survey instrument. Data in this research are presented in three segments: Total Benchmark Class (15 respondents), US Only Class (8 respondents), Excluding-US Class (5 respondents).
To learn more about this report, download a complimentary report excerpt at http://www.best-in-class.com/rr1516.htm.
For related research, visit the Best Practices, LLC Web site at www.best-in-class.com/.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis.
View original content:http://www.prnewswire.com/news-releases/new-pharmaceutical-industry-report-provides-blueprint-for-creating-an-effective-field-medical-team-for-rare-diseases-300733008.html
SOURCE Best Practices, LLC
Subscribe to our Free Newsletters!